Arrowhead Pharmaceuticals (ARWR) vs Veradermics (MANE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Arrowhead Pharmaceuticals is the larger company by market cap ($5.85 billion vs $5.04 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARWR | MANE |
|---|---|---|
| Share price | $41.37 | $119.52 |
| Market cap | $5.85B | $5.04B |
| 1-day change | -5.22% | -3.92% |
| YTD return | -37.69% | — |
| 1-year return | +2.27% | — |
| 5-year return | -42.56% | — |
| EPS (TTM) | $-5.11 | $-3.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $450.82M | — |
| Revenue growth (YoY) | -45.65% | — |
| Net income (latest FY) | $-724.21M | $-70.00M |
| Operating margin | -156.86% | — |
| Net margin | -160.64% | — |
| 52-week high | $95.49 | $156.63 |
| 52-week low | $40.43 | $32.00 |
| Distance from 52-week high | -56.68% | -23.69% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +156.39% | +56.74% |
| Average volume | 2.08M | 738.22K |
| Shares outstanding | 141.37M | 42.20M |
| Employees | 1,062 | 51 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Arrowhead Pharmaceuticals
ARWR stock →Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,062 employees
About Veradermics
MANE stock →Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.
Health Care · Biotechnology: Pharmaceutical Preparations · 51 employees
ARWR vs MANE FAQ
Which is bigger, Arrowhead Pharmaceuticals or Veradermics?
Arrowhead Pharmaceuticals (ARWR) is larger, with a market capitalization of $5.85B compared with $5.04B for Veradermics (MANE).
Are Arrowhead Pharmaceuticals and Veradermics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.